InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Kieffer Tara Lynn, Directeur du Développement de Produits. Officer active across 1 companies, notably Enanta Pharmaceuticals INC. Cumulatively, 3 disclosures have been recorded. The latest transaction was disclosed on 14 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
0327 shares0
Common Stock
SEC:0001062993-22-004520:0·
06,800 shares0
Common Stock
SEC:0001062993-21-011516·
06,800 shares0
Common Stock
SEC:0001062993-21-011516:0·
3 of 3 declarations
About Kieffer Tara Lynn
Tara Lynn Kieffer is the Senior Vice President of New Product Development at Enanta Pharmaceuticals Inc. She oversees the development of new products and innovation within the company. Her expertise in research and development is essential for the success of the company's initiatives. Tara is committed to improving patient outcomes through innovative solutions.
